Cargando…

Multimorbidity and polypharmacy: a risk factor for older patients

Detalles Bibliográficos
Autor principal:	Cucinotta, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171881/ https://www.ncbi.nlm.nih.gov/pubmed/35545999 http://dx.doi.org/10.23750/abm.v93i2.12911

Ejemplares similares

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

The Need for Actions Against Polypharmacy in Older People With Frailty
por: Kojima, Taro
Publicado: (2018)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study
por: Liu, Jiaming, et al.
Publicado: (2023)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Managing Chronic Limb-Threatening Ischaemia in Patients at the Extremes of Older Age Requires a Patient-Focused Approach
por: Cutmore, Carina, et al.
Publicado: (2022)

The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
por: Tian, Fangyuan, et al.
Publicado: (2021)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study
por: Jungo, Katharina Tabea, et al.
Publicado: (2022)

Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2017)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
por: McCarthy, Caroline, et al.
Publicado: (2020)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
por: Adam, Luise, et al.
Publicado: (2023)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Health Professionals Palliative Care Education for Older Adults: Overcoming Ageism, Racism, and Gender Bias
por: Gazaway, Shena B., et al.
Publicado: (2021)

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
por: Laberge, Maude, et al.
Publicado: (2021)

The benefits of understanding complementary medicine options for patients with male factor infertility
por: Wu, Christopher, et al.
Publicado: (2016)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Critical Question in Cardiovascular Risk: Can we use clinical trials to improve the outcomes of patients with hypertension?
por: Kostis, John B.
Publicado: (2021)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice
por: Müller, Beate S, et al.
Publicado: (2020)

Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity
por: Sallevelt, Bastiaan T. G. M., et al.
Publicado: (2021)

Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada
por: Maxwell, Colleen J., et al.
Publicado: (2021)

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Genetic Risk of Alzheimer's Disease – Sleepless with the Enemy
por: Noyce, Alastair J., et al.
Publicado: (2020)

Factors Associated with Medication Non-Adherence among Patients with Multimorbidity and Polypharmacy Admitted to an Intermediate Care Center
por: González-Bueno, Javier, et al.
Publicado: (2021)

Risk-prediction tools in prostate cancer: the challenge of tailoring
por: Morlacco, Alessandro, et al.
Publicado: (2016)

Is number of chiasmata an etiological factor of male infertility?
por: Kurpisz, Maciej, et al.
Publicado: (2014)

Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health
por: Sirois, Caroline, et al.
Publicado: (2019)

Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzle
por: Capogrosso, Paolo, et al.
Publicado: (2017)

Fibroblast Growth Factor-2: A Promising Biomarker for Anxiety and Trauma Disorders
por: Graham, Bronwyn M
Publicado: (2017)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5a9u7tvn40qvk9m8iant5k14sl